Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2463-2472

  Klarquist, Jared ^a   Barfuss, Allison ^a   Kandala, Sridhar ^a   Reust, Mary J ^a   Braun, Ruedi K ^a   Hu, Jennifer ^c   Dilling, Daniel F ^b   McKee, Mark D ^d   Boissy, Raymond E ^e   Love, Robert B ^a   Nishimura, Michael I ^f   Le Poole, I Caroline ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c ILLINOIS MATHEMATICS AND SCIENCE ACADEMY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 100; MELAN A; MELANOMA ANTIGEN; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL INFILTRATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IN VITRO STUDY; LYMPHANGIOLEIOMYOMATOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL;

EID: 73549088735     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090525     Document Type: Article

References (33)

1. Tynski Z, Eisenberg R: Cytologic findings of lymphangioleiomyomatosis in pleural effusion: a case report. Acta Cytol 2007, 51:578-580
2. Reynaud-Gaubert M, Mornex JF, Mal H, Treilhaud M, Dromer C, Qué tant S, Leroy-Ladurie F, Guillemain R, Philit F, Dauriat G, Grenet D, Stern M: Lung transplantation for lymphangioleyomyomatosis: the French experience. Transplantation 2008, 86:515-520
3. Carsillo T, Astrinidis A, Henske EP: Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomeyomatosis. Proc Natl Acad Sci USA 2000, 97:6085-6090
4. Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP: The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med 2001, 163:253-258
5. Moss J, DeCastro R, Patronas NJ, Taveira-DaSilva A: Meningiomas in lymphangioleiomyomatosis. JAMA 2001, 286:1879-1881 6. Johnson SR. Lymphangioleiomyomatosis. Eur J Respir 2006, 27:1056-1065
6. Goncharova EA, Krymskaya VP: Pulmonary lymphangioleiomyomatosis (LAM): Progress and current challenges. J Cell Biochem 2008, 103:369-382
7. Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN: Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleimyomatosis. N Engl J Med 2008, 358:140-151
8. Sugimoto R, Nakao A, Yamane M, Toyooka S, Okazaki M, Aoe M, Seyama K, Date H, Oto T, Sano Y: Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. J Heart Lung Transplant 2008, 27:921-924
9. Watz H, Oltmann A, Kimmel S, Magnussen H, Wirtz H, Kirsten D: Sporadic lymphangioleiomyomatosis: clinical and lung functional characteristics of 32 female patients. Dtsch Med Wochenschr 2008, 133:705-708
10. McCormack FX: Lymphangioleiomyomatosis: a clinical update. Chest 2008, 133:507-516
11. Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A: Comparison of melanoma antigen recognized by T cells (MART-1) to HMB45: additional evidence to support a common lineage for angiomyomlipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod Pathol 1998, 11:699-703
12. Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG: Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 1994, 179:1005-1009
13. Svajdler M, Bohus P, Goc V, Tkácová V: Perivascular epithelioid cell tumor (PEComa) of the liver: a case report and review of the literature. Cesk Patol 2007, 43:18-22
14. Bonifacino JS: Insights into the biogenesis of lysosome-related organelles from the study of the Hermansky-Pudlak syndrome. Ann NY Acad Sci 2004, 1038:103-114
15. Yamaguchi Y, Hearing VJ: Physiological factors that regulate skin pigmentation. Biofactors 2009, 35:193-199
16. Minwalla L, Zhao Y, Le Poole IC, Wickett RR, Boissy RE: Keratinocytes play a role in regulating distribution patterns of recipient melanosomes in vitro. J Invest Dermatol 2001, 117:341-347
17. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA: Identification of the immunodominant peptides of the MART-1 human melanoma antigens recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J Exp Med 1994, 180:347-352
18. Oyarbide-Valencia K, van den Boorn JG, Denman CJ, Li M, Carlson JM, Hernandez C, Nishimura MI, Das PK, Luiten RM, Le Poole IC: Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev 2006, 5:486-492
19. Slingluff CL Jr, Yamshchikov G, Neese P, Galavotti H, Eastham S, Engelhard VH, Kittlesen D, Deacon D, Hibbitts S, Grosh WW, Petroni G, Cohen R, Wiernasz C, Patterson JW, Conway BP, Ross WG: Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res 2001, 7:3012-3024
20. Clay TM, Morse M, Lyerly HK: Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes. Expert Opin Biol Ther 2002, 2:353-360
21. Roszkowski JJ, Lyons GE, Kast WM, Yee C, van Beelen K, Nishimura MI: Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res 2005, 65:1570-1576
22. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W, Das PK: Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996, 148:1219-1228
23. Boissy RE, Liu Y-Y, Medrano EE, Nordlund JJ: Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991, 97:395-404
24. Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A, Wang C, Hernandez-Cuebas L, Seeholzer LF, Nicolas E, Hensley H, Jordan VC, Walker CL, Henske EP: Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci USA 2009, 106:2635-2640
25. Matsumoto Y, Horiba K, Usuki J, Chu SC, Ferrans VJ, Moss J: Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 1999, 21:327-336
26. Guevara-Patiño JA, Engelhorn ME, Turk MJ, Liu C, Duan F, Rizzuto G, Cohen AD, Merghoub T, Wolchok JD, Houghton AN: Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest 2006, 116:1382-1390
27. Harper DC, Theos AC, Herman KE, Tenza D, Raposo G, Marks MS: Premelanosome amyloid-like fibrils are composed of only golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes. J Biol Chem 2008, 283:2307-2322
28. Nordmann R, Andersen E, Trussardi R, Mazer NA: Kinetics of interleukin 2 mRNA and protein produced in the human T-cell line Jurkat and effect of cyclosporin A. Biochemistry 1989, 28:1791-1797
29. Spitler LE: Adjuvant therapy of melanoma. Oncology (Williston Park) 2002, 16(suppl):40-48
30. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A: Role of tumorassociated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006, 25:315-322
31. Duval L, Schmidt H, Kaltoft K, Fode K, Jensen JJ, Sorensen SM, Nishimura MI, von der Maase H: Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma. Clin Cancer Res 2006, 12:1229-1236
32. Kirkwood JM, Tarhini AA, Panelli MC, Moschos SJ, Zarour HM, Butterfield LH, Gogas HJ: Next generation of immunotherapy for melanoma. J Clin Oncol 2008, 26:3445-3455
33. Masri MA: The mosaic of immunosuppressive drugs. Mol Immunol 2003, 39:1073-1077